Watchlist
Loading...
US Stock MarketDetailed Quotes

OPT Opthea

Watchlist
1.700 -0.042-2.41% Close 10/02 16:00 ET
1.750High1.700Low32.27KVolume
Full Hours
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About Opthea Company

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.

Revenue Breakdown

Business Unit:USD
06/30/2023
Stock NameRevenueRatio
Biotechnology and healthcare industry108.41K100.00%
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >